Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah K Westbury

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Future Healthcare Journal|April 1, 2021
Haematology morphology teaching during the COVID-19 pandemic: a UK teaching hospital experienceSarah K Westbury, Andrew Stewart
Seminars in Thrombosis and Hemostasis|May 2, 2019
Genetic Techniques Used in the Diagnosis of Inherited Platelet DisordersAndrew D Mumford, Sarah K Westbury
International Journal of Laboratory Hematology|July 3, 2026
Testing for Non-Severe Heritable Platelet Function DisordersKate Burley, Naomi Cornish, Maria Molina Carretero, et al.
Thrombosis Research|August 3, 2013
High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometrySarah K Westbury, Kurtis Lee, Christopher Reilly-Stitt, et al.
Wellcome Open Research|February 11, 2025
Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolNaomi Cornish, Sarah K Westbury, Matthew T Warkentin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
Associations of tumour somatic mutations with cancer-associated venous thromboembolismNaomi Cornish, Rebecca Ward, Matthew T Warkentin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor TraffickingJane E Norman, Margaret R Cunningham, Matthew L Jones, et al.
Blood|December 18, 2012
Dysfunction of the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemiaSamantha F Moore, Roger W Hunter, Matthew T Harper, et al.
Blood|July 21, 2016
Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathyKate Burley, Claire S Whyte, Sarah K Westbury, et al.
Thrombosis and Haemostasis|September 20, 2013
Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysisSarah K Westbury, Cédric Duval, Helen Philippou, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Future Healthcare Journal|April 1, 2021
Haematology morphology teaching during the COVID-19 pandemic: a UK teaching hospital experienceSarah K Westbury, Andrew Stewart
Seminars in Thrombosis and Hemostasis|May 2, 2019
Genetic Techniques Used in the Diagnosis of Inherited Platelet DisordersAndrew D Mumford, Sarah K Westbury
International Journal of Laboratory Hematology|July 3, 2026
Testing for Non-Severe Heritable Platelet Function DisordersKate Burley, Naomi Cornish, Maria Molina Carretero, et al.
Thrombosis Research|August 3, 2013
High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometrySarah K Westbury, Kurtis Lee, Christopher Reilly-Stitt, et al.
Wellcome Open Research|February 11, 2025
Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolNaomi Cornish, Sarah K Westbury, Matthew T Warkentin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
Associations of tumour somatic mutations with cancer-associated venous thromboembolismNaomi Cornish, Rebecca Ward, Matthew T Warkentin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor TraffickingJane E Norman, Margaret R Cunningham, Matthew L Jones, et al.
Blood|December 18, 2012
Dysfunction of the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemiaSamantha F Moore, Roger W Hunter, Matthew T Harper, et al.
Blood|July 21, 2016
Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathyKate Burley, Claire S Whyte, Sarah K Westbury, et al.
Thrombosis and Haemostasis|September 20, 2013
Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysisSarah K Westbury, Cédric Duval, Helen Philippou, et al.
Pageof 3